大數據AI智能應用提供商數說故事獲小米(01810.HK)領投2.5億人幣融資
一站式大數據及AI智能應用提供商數說故事宣佈,完成由小米(01810.HK)及順爲資本聯合領投的C+輪融資,涉及2.5億元人民幣,所募集資金將用於加速升級PaaS生態體系、高效更新應用產品、持續深耕行業生態圈,以及全面開拓出海業務。
數說故事表示,成立至今與伊利(600887.SH)、雀巢、寶潔、聯合利華、資生堂、騰訊(00700.HK)、華爲、英特爾、小米、屈臣氏、周大福(01929.HK)等知名企業長期合作,持續延展至更多業務場景,企業續費率超過100%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.